Utilising adult stem cells to treat liver disease – from basic science to clinical trials

Professor Newsome’s laboratory focusses on trafficking and role of both adult and embryonic stem cells in the context of liver injury. This has allowed identification of the key molecular interactions that regulate the successful engraftment of such cells into the liver. In the largest randomised controlled trial of stem cell therapy so far,  he is treating patients with liver cirrhosis. This has the potential for major impact in the NHS given the rising levels of liver cirrhosis in the UK and the lack of effective therapies at present.

Professor Philip Newsome is Professor of Experimental Hepatology and Clinical Director of the Birmingham University Stem Cell Centre. For more information on Professor Newsome please visit his webpage.